FITABEO THERAPEUTICS LIMITED

FITABEO THERAPEUTICS LIMITED is an active private limited company incorporated on 8 July 2022 and registered in Scotland. Its registered office is at Suite 2, Orchard Brae House, 30 Queensferry Road, Edinburgh, EH4 2HS, United Kingdom. Its principal activities are manufacture of pharmaceutical preparations (SIC 21200) and research and experimental development on biotechnology (SIC 72110).

Mr Alexander Balfour Mullen is a person with significant control who holds 25-50% of the shares and voting rights. Mr Mallikarjun Chityala Narayana is a person with significant control who holds 25-50% of the shares and voting rights. The board consists of two directors: CHITYALA NARAYANA, Mallikarjun (appointed 8 July 2022) and MULLEN, Alexander Balfour (appointed 21 September 2022). The company has been served by two former officers who have since resigned.

Its regulatory record is clean, with no charges, no insolvency proceedings and no liquidation history. The company filed its most recent unaudited-abridged accounts, covering the period to 31 March 2025, on 27 May 2025. The next accounts are due by 31 December 2026. Its most recent confirmation statement was made up to 3 April 2026. The next is due by 17 April 2027. 32 filings are recorded against the company at Companies House, most recently a confirmation statement filing on 7 April 2026.